Detalhe da pesquisa
1.
Chest CT scan plus x-ray versus chest x-ray for the follow-up of completely resected non-small-cell lung cancer (IFCT-0302): a multicentre, open-label, randomised, phase 3 trial.
Lancet Oncol
; 23(9): 1180-1188, 2022 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-35964621
2.
A defect of amphiregulin release predicted longer survival independently of YAP expression in patients with pleural mesothelioma in the IFCT-0701 MAPS phase 3 trial.
Int J Cancer
; 150(11): 1889-1904, 2022 06 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35262190
3.
First-line carboplatin plus pemetrexed with pemetrexed maintenance in HIV-positive patients with advanced non-squamous non-small cell lung cancer: the phase II IFCT-1001 CHIVA trial.
Eur Respir J
; 56(2)2020 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-32444410
4.
MST1/Hippo promoter gene methylation predicts poor survival in patients with malignant pleural mesothelioma in the IFCT-GFPC-0701 MAPS Phase 3 trial.
Br J Cancer
; 120(4): 387-397, 2019 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-30739911
5.
Routine molecular profiling of patients with advanced non-small-cell lung cancer: results of a 1-year nationwide programme of the French Cooperative Thoracic Intergroup (IFCT).
Lancet
; 387(10026): 1415-1426, 2016 Apr 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-26777916
6.
EGFR tyrosine kinase inhibitors versus chemotherapy in EGFR wild-type pre-treated advanced nonsmall cell lung cancer in daily practice.
Eur Respir J
; 50(2)2017 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-28798090
7.
Erlotinib versus carboplatin and paclitaxel in advanced lepidic adenocarcinoma: IFCT-0504.
Eur Respir J
; 46(5): 1440-50, 2015 Nov.
Artigo
em Inglês
| MEDLINE | ID: mdl-26381515
8.
STK11/LKB1 alterations worsen the poor prognosis of KRAS mutated early-stage non-squamous non-small cell lung carcinoma, results based on the phase 2 IFCT TASTE trial.
Lung Cancer
; 190: 107508, 2024 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-38428265
9.
Outcome of Patients With Resected Early-Stage Non-small Cell Lung Cancer and EGFR Mutations: Results From the IFCT Biomarkers France Study.
Clin Lung Cancer
; 24(1): 1-10, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36180314
10.
Main conclusions and perspectives from the collective scientific assessment of the effects of plant protection products on biodiversity and ecosystem services along the land-sea continuum in France and French overseas territories.
Environ Sci Pollut Res Int
; 2023 Apr 26.
Artigo
em Inglês
| MEDLINE | ID: mdl-37099095
11.
Neoadjuvant durvalumab for resectable non-small-cell lung cancer (NSCLC): results from a multicenter study (IFCT-1601 IONESCO).
J Immunother Cancer
; 10(10)2022 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-36270733
12.
Combination of Trastuzumab, Pertuzumab, and Docetaxel in Patients With Advanced Non-Small-Cell Lung Cancer Harboring HER2 Mutations: Results From the IFCT-1703 R2D2 Trial.
J Clin Oncol
; 40(7): 719-728, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-35073148
13.
Tailoring maintenance chemotherapy upon response to induction chemotherapy as compared with pemetrexed continuation maintenance in advanced non-squamous NSCLC patients: Results of the IFCT-GFPC-1101 multicenter randomized phase III trial.
Lung Cancer
; 164: 84-90, 2022 02.
Artigo
em Inglês
| MEDLINE | ID: mdl-35051725
14.
Lorlatinib for advanced anaplastic lymphoma kinase-positive non-small cell lung cancer: Results of the IFCT-1803 LORLATU cohort.
Eur J Cancer
; 166: 51-59, 2022 05.
Artigo
em Inglês
| MEDLINE | ID: mdl-35278825
15.
Sensitivity to chemotherapy/tyrosine kinase inhibitors of mucinous lepidic adenocarcinoma should be tested in a phase III trial?
Eur Respir J
; 47(6): 1890-1, 2016 06.
Artigo
em Inglês
| MEDLINE | ID: mdl-27246084
16.
Assessment of nivolumab in HIV-Infected patients with advanced non-small cell lung cancer after prior chemotherapy. The IFCT-1602 CHIVA2 phase 2 clinical trial.
Lung Cancer
; 158: 146-150, 2021 08.
Artigo
em Inglês
| MEDLINE | ID: mdl-34217967
17.
Circulating tumor DNA in advanced non-small-cell lung cancer patients with HIV is associated with shorter overall survival: Results from a Phase II trial (IFCT-1001 CHIVA).
Lung Cancer
; 157: 124-130, 2021 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-34016488
18.
Development and Validation of a Simplified Prognostic Score in SCLC.
JTO Clin Res Rep
; 1(1): 100016, 2020 Mar.
Artigo
em Inglês
| MEDLINE | ID: mdl-34589918
19.
Circulating Tumor DNA as a Prognostic Determinant in Small Cell Lung Cancer Patients Receiving Atezolizumab.
J Clin Med
; 9(12)2020 Nov 27.
Artigo
em Inglês
| MEDLINE | ID: mdl-33261056
20.
Switch maintenance chemotherapy versus observation after carboplatin and weekly paclitaxel doublet chemotherapy in elderly patients with advanced non-small cell lung cancer: IFCT-1201 MODEL trial.
Eur J Cancer
; 138: 193-201, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32898792